Skip to main content
Top
Published in: Virology Journal 1/2016

Open Access 01-12-2016 | Research

Changing etiologies and outcome of liver failure in Southwest China

Authors: Gui-Juan Xie, Hui-Yan Zhang, Qing Chen, Hui-Min Liu, Jian-Ping You, Sha Yang, Qing Mao, Xu-Qing Zhang

Published in: Virology Journal | Issue 1/2016

Login to get access

Abstract

Background

The prognosis of liver failure depends greatly on the underlying cause, and there were few data about the prognosis, etiologies or trigger factors of liver failure in China based on long-term and large samples cohorts.

Methods

We screened out 3171 liver failure cases from 25467 patients hospitalized in our department between 2000 and 2012 according to Chinese criteria, and determined their etiologies and prognosis.

Results

97.3 % cases were associated with at least one of 25 identified factors. The 3 leading etiologies were HBV (91.6 %), alcohol (18.1 %) and antiviral therapy (AVT) related hepatitis B flares (6.7 %). Acute-on-chronic liver failure (ACLF) accounted for 92.1 % of all cases. 96.5 % ACLF cases were associated with HBV, in which the percentage of AVT related flares increased from 0 % in 2000 up to 11.5 % in 2012, and hepatitis virus superinfection declined from peak 19.3 % in 2002 down to 2.5 % in 2012. Three-month spontaneous survival (SS) rate of 3171 cases was 31.4 %, but improved from 17.4 % in 2000 up to 40.4 % in 2012. SS was significantly different among various etiological groups (P = 0.000). In HBV related liver failure aged 25 to 54 years, males accounted for 87.6 %, and had a progressively decreased SS with increasing age. From 25 to 54 years, SS was lower in male than in female HBV related liver failure, and having significant difference in cases of ages 40 to 44 years (27.6 % versus 50.9 %, P = 0.001).

Conclusion

Etiologies of liver failure were numerous and varied in southwest China. HBV was the most leading cause of liver failure, especially in ACLF. AVT related flares had become the third leading cause of ACLF. The prognosis of liver failure remained poor, but had markedly improved in recently 3 years. Middle-aged male HBsAg carriers had an extremely higher risk for liver failure and worse prognosis compared to female.
1.
Etiologies of liver failure were numerous and varied in southwest China. HBV infection is the main cause of liver failure in southwest China, especially the major cause of ACLF. Antiviral related liver failure, especially the NUCs withdrawal induced ACLF were extremely increased, which has replaced the superinfection as the third important cause of HBV-ACLF.
 
2.
The prognosis of liver failure is still poor, but the spontaneous survival rate showed a trend of steady rise in recent years. The prognosis of patients with liver failure caused by different causes also exists certain difference, the more damage factors bulls the worse prognosis.
 
3.
The prognosis of the HBV and HCV reactivation induced by the steroids was poor.Interferon treatment of CHB in ACLF although rare, but should be taken into consideration seriously.
 
4.
Patients with liver failure caused by different etiologies showed larger differences of gender and age distribution. Gender and age are the important factors with the occurrence and prognosis of HBV-ACLF.
 
Literature
1.
go back to reference Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269–82.CrossRefPubMedPubMedCentral Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269–82.CrossRefPubMedPubMedCentral
2.
go back to reference Liver Failure and Artificial Liver Group CSoID, CMA; Severe Liver Disease and Artificial Liver Group. Chinese Society of Hepatology, CMA. Guideline for diagnosis and treatment of liver failure. Chin J Clin Infect Dis. 2012;5:321–7. Liver Failure and Artificial Liver Group CSoID, CMA; Severe Liver Disease and Artificial Liver Group. Chinese Society of Hepatology, CMA. Guideline for diagnosis and treatment of liver failure. Chin J Clin Infect Dis. 2012;5:321–7.
3.
go back to reference Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.CrossRefPubMed Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.CrossRefPubMed
4.
go back to reference Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336–48.CrossRefPubMed Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336–48.CrossRefPubMed
5.
7.
go back to reference Mahtab MA, Rahman S, Khan M, Karim MF. Hepatitis E virus is a leading cause of acute-on-chronic liver disease: experience from a tertiary centre in Bangladesh. Hepatobiliary Pancreat Dis Int. 2009;8:50–2.PubMed Mahtab MA, Rahman S, Khan M, Karim MF. Hepatitis E virus is a leading cause of acute-on-chronic liver disease: experience from a tertiary centre in Bangladesh. Hepatobiliary Pancreat Dis Int. 2009;8:50–2.PubMed
8.
go back to reference Khuroo MS, Rustgi VK, Dawson GJ, Mushahwar IK, Yattoo GN, Kamili S, et al. Spectrum of hepatitis E virus infection in India. J Med Virol. 1994;43:281–6.CrossRefPubMed Khuroo MS, Rustgi VK, Dawson GJ, Mushahwar IK, Yattoo GN, Kamili S, et al. Spectrum of hepatitis E virus infection in India. J Med Virol. 1994;43:281–6.CrossRefPubMed
9.
go back to reference Ke WM, Li XJ, Yu LN, Lai J, Li XH, Gao ZL, et al. Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. J Gastroenterol. 2006;41:347–51.CrossRefPubMed Ke WM, Li XJ, Yu LN, Lai J, Li XH, Gao ZL, et al. Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. J Gastroenterol. 2006;41:347–51.CrossRefPubMed
10.
go back to reference Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed
12.
go back to reference Liu XY, Hu JH, Wang HF, Chen JM. Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-on-chronic liver failure. Zhonghua Gan Zang Bing Za Zhi. 2008;16:772–5.PubMed Liu XY, Hu JH, Wang HF, Chen JM. Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-on-chronic liver failure. Zhonghua Gan Zang Bing Za Zhi. 2008;16:772–5.PubMed
13.
go back to reference Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–37. 1437 e1421-1429.CrossRefPubMed Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–37. 1437 e1421-1429.CrossRefPubMed
14.
go back to reference Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47:849–61.CrossRefPubMedPubMedCentral Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47:849–61.CrossRefPubMedPubMedCentral
15.
go back to reference Zhang NP, Reijnders JG, Perquin M, Hansen BE, Janssen HL. Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B. J Viral Hepat. 2011;18:e252–257.CrossRefPubMed Zhang NP, Reijnders JG, Perquin M, Hansen BE, Janssen HL. Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B. J Viral Hepat. 2011;18:e252–257.CrossRefPubMed
16.
go back to reference Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635–9.CrossRefPubMed Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635–9.CrossRefPubMed
17.
go back to reference Chao DC, Hu KQ. Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther. 2013;7:777–88.PubMedPubMedCentral Chao DC, Hu KQ. Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther. 2013;7:777–88.PubMedPubMedCentral
18.
go back to reference Sperl J. Reactivation of chronic hepatitis B. Vnitr Lek. 2013;59:591–6.PubMed Sperl J. Reactivation of chronic hepatitis B. Vnitr Lek. 2013;59:591–6.PubMed
19.
go back to reference Kusumoto S, Tanaka Y. Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 1. Reactivation of hepatitis B virus and hepatitis C virus following immunosuppressive therapy. Nihon Naika Gakkai Zasshi. 2014;103:1645–53.CrossRefPubMed Kusumoto S, Tanaka Y. Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 1. Reactivation of hepatitis B virus and hepatitis C virus following immunosuppressive therapy. Nihon Naika Gakkai Zasshi. 2014;103:1645–53.CrossRefPubMed
20.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550–7.CrossRefPubMed Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550–7.CrossRefPubMed
21.
go back to reference Shibuya A, Tanaka K, Miyakawa H, Shibata M, Takatori M, Sekiyama K, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology. 2002;35:1172–8.CrossRefPubMed Shibuya A, Tanaka K, Miyakawa H, Shibata M, Takatori M, Sekiyama K, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology. 2002;35:1172–8.CrossRefPubMed
22.
go back to reference Yan Z, Tan W, Dan Y, Zhao W, Deng C, Wang Y, et al. Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Med Genet. 2012;13:49.CrossRefPubMedPubMedCentral Yan Z, Tan W, Dan Y, Zhao W, Deng C, Wang Y, et al. Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Med Genet. 2012;13:49.CrossRefPubMedPubMedCentral
23.
go back to reference Kim JY, Jung WH, Koo JS. Expression of Reactive Oxygen Species-Related Proteins according to Androgen and HER-2 Status in Estrogen Receptor-Negative Breast Cancer. Pathobiology. 2014;81:215–25.CrossRefPubMed Kim JY, Jung WH, Koo JS. Expression of Reactive Oxygen Species-Related Proteins according to Androgen and HER-2 Status in Estrogen Receptor-Negative Breast Cancer. Pathobiology. 2014;81:215–25.CrossRefPubMed
24.
go back to reference Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71–87. viii.CrossRefPubMed Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71–87. viii.CrossRefPubMed
26.
27.
go back to reference Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43:1311–6.CrossRefPubMed Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43:1311–6.CrossRefPubMed
28.
go back to reference Szpakowski JL, Tucker LY. Causes of death in patients with hepatitis B: a natural history cohort study in the United States. Hepatology. 2013;58:21–30.CrossRefPubMed Szpakowski JL, Tucker LY. Causes of death in patients with hepatitis B: a natural history cohort study in the United States. Hepatology. 2013;58:21–30.CrossRefPubMed
Metadata
Title
Changing etiologies and outcome of liver failure in Southwest China
Authors
Gui-Juan Xie
Hui-Yan Zhang
Qing Chen
Hui-Min Liu
Jian-Ping You
Sha Yang
Qing Mao
Xu-Qing Zhang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2016
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-016-0536-0

Other articles of this Issue 1/2016

Virology Journal 1/2016 Go to the issue